November 28, 2016 - By Ruchi Gupta
Mr. Albert Eilender, the important Chairman at Aceto Corp has a few days ago been involved with a stock market transaction of 18,500 shares of the Pinksheet-listed company, valued at $19.9 per share. The total transaction value was for of $367,813 US Dollars. Right now, Albert Eilender holds a total of 265,479 shares or 0.88% of Aceto Corp’s market cap (share price times the number of shares outstanding).
Insitutional Activity: The institutional sentiment increased to 1.22 in Q2 2016. Its up 0.36, from 0.86 in 2016Q1. The ratio increased, as 16 funds sold all Aceto Corporation shares owned while 49 reduced positions. 11 funds bought stakes while 45 increased positions. They now own 23.91 million shares or 7.56% less from 25.86 million shares in 2016Q1.
King Luther Cap Management holds 0.17% of its portfolio in Aceto Corporation (NASDAQ:ACET) for 806,343 shares. Jpmorgan Chase And owns 217,969 shares or 0% of their US portfolio. Voya Investment Mgmt Ltd Llc, a Georgia-based fund reported 12,357 shares. Goldman Sachs Group last reported 0% of its portfolio in the stock. Hillcrest Asset Management Ltd accumulated 2.2% or 398,882 shares. Blair William & Company Il has invested 0% of its portfolio in Aceto Corporation (NASDAQ:ACET). Keeley Asset Mngmt Corp accumulated 47,700 shares or 0.04% of the stock. Tradewinds Glob Investors Ltd Liability Co last reported 0.02% of its portfolio in the stock. Sei Investments Communications has 95 shares for 0% of their US portfolio. The California-based Blackrock Fund Advsrs has invested 0.01% in Aceto Corporation (NASDAQ:ACET). The Maryland-based Columbia Prtn L L C Inv Mgmt has invested 0.16% in Aceto Corporation (NASDAQ:ACET). Putnam Invs Lc accumulated 0% or 56,549 shares. Shinko Asset Mgmt Limited accumulated 167,853 shares or 0.03% of the stock. Prudential Financial, a New Jersey-based fund reported 71,771 shares. Arizona State Retirement last reported 15,349 shares in the company.
Insider Transactions: Since May 31, 2016, the stock had 0 insider purchases, and 31 selling transactions for $2.97 million net activity. 10,945 shares with value of $254,420 were sold by GUCCIONE SALVATORE J SR on Wednesday, July 6. Bartone Raymond also sold $31,542 worth of Aceto Corporation (NASDAQ:ACET) on Thursday, September 1. Another trade for 1,321 shares valued at $26,222 was made by Kippley Terry on Thursday, September 1. The insider Alaimo Charles John sold $50,955. NOETZLI HANS C had sold 6,000 shares worth $109,906. On Thursday, July 7 DEBENEDITTIS FRANK sold $76,426 worth of the stock or 3,275 shares. 3,250 Aceto Corporation (NASDAQ:ACET) shares with value of $74,098 were sold by Srinivasan Satish.
The stock increased 0.40% or $0.08 during the last trading session, hitting $19.84. About 329,735 shares traded hands or 44.53% up from the average. Aceto Corporation (NASDAQ:ACET) has declined 14.97% since April 25, 2016 and is downtrending. It has underperformed by 20.99% the S&P500.
Aceto Corporation is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The company has a market cap of $596.82 million. The Company’s business is organized along product lines into three divisions: Human Health, Pharmaceutical Ingredients and Performance Chemicals. It has a 19.72 P/E ratio. As of June 30, 2016, it distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the agricultural, coatings and industrial chemical industries.
According to Zacks Investment Research, “Aceto Corporation markets, sells and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products and specialty chemicals. The company’s operating segment consists of Human Health, Pharmaceutical Ingredients and Performance Chemicals. Human Health segment supplies raw materials used in the production of nutritional and packaged dietary supplements. It markets and distributes its generic prescription and over the counter pharmaceutical products. Pharmaceutical Ingredients segment offers active pharmaceutical ingredients and pharmaceutical intermediates. Performance Chemicals segment provides specialty chemicals. It serves chemical, agricultural, human health and pharmaceutical industries. The company operates primarily in United States, Europe, and Asia. Aceto Corporation and is headquartered in Port Washington, New York.”
Analysts await Aceto Corporation (NASDAQ:ACET) to report earnings on February, 2. They expect $0.35 EPS, down 2.78% or $0.01 from last year’s $0.36 per share. ACET’s profit will be $10.53M for 14.17 P/E if the $0.35 EPS becomes a reality. After $0.28 actual EPS reported by Aceto Corporation for the previous quarter, Wall Street now forecasts 25.00% EPS growth.
More notable recent Aceto Corporation (NASDAQ:ACET) news were published by: Fool.com which released: “Why Shares of Aceto Corporation Plunged 23% Today” on August 26, 2016, also Streetinsider.com with their article: “ACETO Corp (ACET) Announces $412M Acquisition of Certain Assets from Citron ..” published on November 03, 2016, Globenewswire.com published: “ACETO Corporation Schedules Fourth Quarter & Fiscal 2016 Financial Results ..” on August 12, 2016. More interesting news about Aceto Corporation (NASDAQ:ACET) were released by: Globenewswire.com and their article: “ACETO Corporation Schedules First Quarter Fiscal 2017 Financial Results News ..” published on October 21, 2016 as well as Globenewswire.com‘s news article titled: “ACETO Corporation Announces $125 Million Convertible Notes Offering” with publication date: November 09, 2015.
Aceto Corporation (Aceto), incorporated on June 13, 1947, is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company’s business is organized along product lines into three divisions: Human Health, Pharmaceutical Ingredients and Performance Chemicals. As of June 30, 2016, the Company distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical industries. The Firm has presence in China, Germany, France, The Netherlands, Singapore, India, Hong Kong, Philippines, the United Kingdom and the United States.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Ruchi Gupta